215 related articles for article (PubMed ID: 38415257)
1. Plasmablastic lymphoma: current knowledge and future directions.
Li JW; Peng HL; Zhou XY; Wang JJ
Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
[TBL] [Abstract][Full Text] [Related]
2. Plasmablastic lymphoma: An update.
Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
[TBL] [Abstract][Full Text] [Related]
3. High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma.
Miao L; Guo N; Feng Y; Rao H; Wang F; Huang Q; Huang Y
Histopathology; 2020 Jan; 76(2):201-211. PubMed ID: 31348551
[TBL] [Abstract][Full Text] [Related]
4. [Plasmablastic lymphoma].
Fernández-Álvarez R; Sancho JM; Ribera JM
Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
[TBL] [Abstract][Full Text] [Related]
5. Plasmablastic lymphoma: from genetics to treatment.
Frontzek F; Hailfinger S; Lenz G
Leuk Lymphoma; 2023 Apr; 64(4):799-807. PubMed ID: 36577021
[TBL] [Abstract][Full Text] [Related]
6. From the archives of MD Anderson Cancer Center: Plasmablastic lymphoma presenting as a kidney mass in an immunocompetent patient: Case report and literature review.
Gietzen R; Muthukumarana V; Bhargava P; Vozniuk D; Thakral B; Medeiros LJ; Lyapichev KA
Ann Diagn Pathol; 2023 Dec; 67():152186. PubMed ID: 37541853
[TBL] [Abstract][Full Text] [Related]
7. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
Harmon CM; Smith LB
Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.
Shi D; Gao L; Wan XC; Li J; Tian T; Hu J; Zhang QL; Su YF; Zeng YP; Hu ZJ; Yu BH; Li XQ; Wei P; Li JW; Zhou XY
BMC Med; 2022 Dec; 20(1):483. PubMed ID: 36522654
[TBL] [Abstract][Full Text] [Related]
9. The biology and treatment of plasmablastic lymphoma.
Castillo JJ; Bibas M; Miranda RN
Blood; 2015 Apr; 125(15):2323-30. PubMed ID: 25636338
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis of HIV-negative plasmablastic lymphoma].
Chen Y; Liu Y; Luo D; Zhang F; Xu F; Ge Y; Luo X; Chen J
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):548-52. PubMed ID: 26705177
[TBL] [Abstract][Full Text] [Related]
11. Plasmablastic Lymphoma: Past, Present, and Future.
Kaur S; Kollimuttathuillam S
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):e253-e259. PubMed ID: 37453866
[TBL] [Abstract][Full Text] [Related]
12. CD3-positive plasmablastic lymphoma reported in two cases: A potential diagnostic caveat.
Wong YP; Masir N; Chew MX
Indian J Pathol Microbiol; 2021; 64(3):579-583. PubMed ID: 34341278
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the molecular landscape: a comparative analysis of PI3K and MAPK signaling pathways in plasmablastic lymphoma and diffuse large B-cell lymphoma with therapeutic implications.
Mansoor A; Akhter A; Kamran H; Minoo P; Stewart D
Hum Pathol; 2023 Nov; 141():102-109. PubMed ID: 37524252
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
[TBL] [Abstract][Full Text] [Related]
15. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
[TBL] [Abstract][Full Text] [Related]
17. MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry.
Pather S; Mashele T; Willem P; Patel M; Perner Y; Motaung M; Nagiah N; Waja F; Philip V; Lakha A; Hale MJ
Histopathology; 2021 Jul; 79(1):86-95. PubMed ID: 33450085
[TBL] [Abstract][Full Text] [Related]
18. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
19. Oral plasmablastic lymphoma: A case report.
Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.
Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T
Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
